Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
24.41
+0.58 (2.43%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3.11 billion as of October 9, 2026. It is the 5,106th most valuable company in the world and the 1,474th biggest in the United States. Its market cap has increased by 94.04% in one year.
Market Cap
3.11B
Enterprise Value
2.57B
1-Year Change
94.04%
Global Rank
Country Rank
#1,474 United States
Category
ChartMarket Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.11B, an increase of 338.95%. That is a compound annual growth rate of 18.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 3.11B | 20.80% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 3.53B |
| IDEAYA Biosciences | 3.50B |
| Acadia Pharmaceuticals | 3.39B |
| Viking Therapeutics | 3.33B |
| Tarsus Pharmaceuticals | 3.23B |
| Celcuity | 3.22B |
| Denali Therapeutics | 3.06B |
| Arcutis Biotherapeutics | 3.04B |